A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : aPT
Long Form : antiprothrombin
No. Year Title Co-occurring Abbreviation
2020 Prevalence of autoantibodies directed against prothrombin in unprovoked venous thromboembolism. APS, PT, VTE
2019 Impaired ankle-brachial index in antiphospholipid syndrome: Beyond the traditional risk factors. abeta2GPI, ABI, APS
2019 Splenic infarction associated with transient anti-prothrombin antibodies is a rare manifestation of acute Mycoplasma pneumoniae infection. aPL
2019 Validity of Coagulation Activation Markers in Antiphospholipid Syndrome: A Systematic Review and Meta-analysis with a Short Data Report. aCL, aPL, APS, ES, LA, PAPS, SLE, TAT
2014 A novel ELISA system for simultaneous detection of six subclasses of anti-phospholipid antibodies for prediction of thrombotic complications among SLE patients. abeta2GPI, aCL, aPLs, aPS, LA, SLE
2014 Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. APS, CI, OR
2014 New tests to detect antiphospholipid antibodies: antiprothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies. APS, LA
2014 Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. aCL, aPE, aPLs, aPS, beta2GpI, CI, LA, OR, SLE
2014 The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6months of observation. abeta2GPI, aCL, APS, LA
10  2013 Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases. IBD
11  2012 Antibodies to prothrombin. aCL, aPL, APS, LA
12  2012 Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome. CI, ELISA, OR, PAPS
13  2012 Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities. aCL, anti-beta2GPI, aPE, aPL, APS, LA, SLE, YI
14  2012 The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome. PAPS, PT
15  2011 Antiphospholipid antibodies in black south africans with hiv and acute coronary syndromes: prevalence and clinical correlates. aCL, ACS, aPL, HAART
16  2010 Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). APS, LA
17  2010 Rational Laboratory Diagnostics of Antiphospholipid Antibodies: Anti-Cardiolipin, Anti-beta2-Glycoprotein I, Anti-Prothrombin and Anti-Annexin V Antibodies. aANX V, aCL, anti-beta2GPI, aPL
18  2009 Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome? aCL, aPS, APS, AUC, LA, RPL, WSP
19  2007 Increased plasma concentrations of antiprothrombin antibodies in women with recurrent spontaneous abortions. RSA
20  2006 Prevalence and clinical correlates of anti-phospholipid antibodies in South Africans with systemic lupus erythematosus. abeta2GP1, aCL, aPL, APS, Ig, LA, SLE
21  2006 Prevalence of antibodies against oxidised LDL in a cohort of 163 patients with positive anti-phospholipid antibodies and recent thrombosis. a-oxLDL, a-PP, abeta2GPI, aCL
22  2006 Prevalence of antiphospholipid antibodies in Chilean patients with rheumatoid arthritis. aCL, aPL, LA, RA
23  2005 Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals. aCL, aPL, DM, LA
24  2004 Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. aCL, anti-B2GPI, aPS, APS, PV, SLE
25  2004 Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism. VTE
26  2004 Antiphospholipid antibodies and hypertension. abeta2GP1, aCL, aPL, APS, LA, RAS
27  2004 High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. aPL, APS, DVT, LA, PE
28  2004 Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis. aCL, aPL, OR
29  2003 Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. aCL, aPA, aPI, APS, aPS, CI, LAC, OR, ROC, SLE, TU
30  2003 Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients. aCL, aPL, aPlt, aPlt, HIV, LA
31  2002 Prevalence of anti-cardiolipin, anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy. aCL, AEDs, ANAs, anti-beta2GPI, CT, ENAs, MRI, SLE
32  2002 [Valvular heart disease in patients with anti-phospholipid syndrome]. abeta2-PGI, aCL, AL, APA, APS, SLE
33  2001 The epidemiology of the antiphospholipid syndrome: who is at risk? aCL, aPL, beta 2-GPI, LA
34  2000 Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestations. aCL, aPI, aPL, aPS, beta 2GPI, beta2GPI
35  2000 Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. aANX, aCL, APS, LAC
36  1997 Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. aCL, LAC, SLE